Page last updated: 2024-08-22

camptothecin and belinostat

camptothecin has been researched along with belinostat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, DH; Hong, YS; Jang, SJ; Jung, KA; Kim, JC; Kim, SM; Kim, TW; Lee, JS; Moon, DH; Na, YS; Ryu, MH	1
Alharbi, SA; Chan, CEL; Chinnathambi, A; Goh, BC; Ho, PC; Lee, LS; Lee, SC; Lim, SW; Sethi, G; Soo, R; Wang, L; Wong, AL; Wong, FC; Yong, WP	1

Other Studies

2 other study(ies) available for camptothecin and belinostat

Article	Year
The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:2 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Female; HCT116 Cells; Histone Deacetylase Inhibitors; HT29 Cells; Humans; Hydroxamic Acids; Irinotecan; Mice; Mice, Nude; Prodrugs; Random Allocation; Sulfonamides; Topoisomerase I Inhibitors; Tumor Burden; Whole Body Imaging; Xenograft Model Antitumor Assays	2011
Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1. Oncotarget, 2017, Jun-20, Volume: 8, Issue:25 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chromatography, Liquid; Drug Interactions; Glucuronosyltransferase; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Irinotecan; Mass Spectrometry; Microsomes, Liver; Sulfonamides	2017

Article

Year

The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.

Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:2

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Female; HCT116 Cells; Histone Deacetylase Inhibitors; HT29 Cells; Humans; Hydroxamic Acids; Irinotecan; Mice; Mice, Nude; Prodrugs; Random Allocation; Sulfonamides; Topoisomerase I Inhibitors; Tumor Burden; Whole Body Imaging; Xenograft Model Antitumor Assays

2011

Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1.

Oncotarget, 2017, Jun-20, Volume: 8, Issue:25

Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chromatography, Liquid; Drug Interactions; Glucuronosyltransferase; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Irinotecan; Mass Spectrometry; Microsomes, Liver; Sulfonamides

2017